RENAU.UNSP.ARD 1/5 EO-20
Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; reagents; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transp… Read more
Market Cap & Net Worth: RENAU.UNSP.ARD 1/5 EO-20 (56S0)
RENAU.UNSP.ARD 1/5 EO-20 (F:56S0) has a market capitalization of $15.68 Billion (€15.27 Billion) as of March 18, 2026. Listed on the F stock exchange, this Germany-based company holds position #10824 globally and #1154 in its home market, demonstrating a -5.99% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying RENAU.UNSP.ARD 1/5 EO-20's stock price €15.70 by its total outstanding shares 972900300 (972.90 Million).
RENAU.UNSP.ARD 1/5 EO-20 Market Cap History: 2022 to 2026
RENAU.UNSP.ARD 1/5 EO-20's market capitalization history from 2022 to 2026. Data shows change from $29.51 Billion to $15.68 Billion (-18.94% CAGR).
RENAU.UNSP.ARD 1/5 EO-20 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how RENAU.UNSP.ARD 1/5 EO-20's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 56S0 by Market Capitalization
Companies near RENAU.UNSP.ARD 1/5 EO-20 in the global market cap rankings as of March 18, 2026.
Key companies related to RENAU.UNSP.ARD 1/5 EO-20 by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #99 globally with a market cap of $170.64 Billion USD.
- EssilorLuxottica Société anonyme (PINK:ESLOF): Ranked #263 globally with a market cap of $78.22 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #355 globally with a market cap of $61.46 Billion USD ( €59.87 Billion EUR).
- Becton Dickinson and Company (NYSE:BDX): Ranked #472 globally with a market cap of $45.52 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #99 | Intuitive Surgical Inc | NASDAQ:ISRG | $170.64 Billion | $483.46 |
| #263 | EssilorLuxottica Société anonyme | PINK:ESLOF | $78.22 Billion | $265.00 |
| #355 | EssilorLuxottica S. A. | PA:EL | $61.46 Billion | €203.90 |
| #472 | Becton Dickinson and Company | NYSE:BDX | $45.52 Billion | $160.27 |
RENAU.UNSP.ARD 1/5 EO-20 Historical Marketcap From 2022 to 2026
Between 2022 and today, RENAU.UNSP.ARD 1/5 EO-20's market cap moved from $29.51 Billion to $ 15.68 Billion, with a yearly change of -18.94%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €15.68 Billion | -23.04% |
| 2025 | €20.37 Billion | +12.71% |
| 2024 | €18.08 Billion | -21.07% |
| 2023 | €22.90 Billion | -22.40% |
| 2022 | €29.51 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of RENAU.UNSP.ARD 1/5 EO-20 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $15.68 Billion USD |
| MoneyControl | $15.68 Billion USD |
| MarketWatch | $15.68 Billion USD |
| marketcap.company | $15.68 Billion USD |
| Reuters | $15.68 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.